Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005
Prognostic role of serum bilirubin levels in pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016
The role of serum ischemia modified albumin level for the diagnosis of pulmonary thromboembolism Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism Year: 2013
Role of serum adiponectin in COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Biomarkers in COPD- The role of resistin and leptin Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015
Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013
Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013
Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015
Serum BNP levels in COPD, asthma-COPD-overlap-syndrome, smokers and never-smokers Source: International Congress 2016 – Systemic biomarkers Year: 2016
Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
Shock index as a prognostic value in risk stratification of patients with acute pulmonary embolism Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome Source: International Congress 2015 – COPD: notable points Year: 2015
Relation of plasma osteopontin levels with the clinical course in patients with COPD Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014
Associations of serological markers of sICAM-1, IL-1ß, MIF and su-PAR with 3-month mortality in acute exacerbation of Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020
Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function? Source: International Congress 2014 – Acute pulmonary embolism Year: 2014
Serum apelin 13 levels in patients with pulmonary embolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014
Serum 1,25(OH)2D levels and arterial hypertension (AH) in sarcoidosis patients Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009
Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010
Serum miR-122 levels correlated to the coagulation disorders of severe sepsis patients Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013